We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+13.82%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.5B
AUM Growth
+$378M
Cap. Flow
+$252M
Cap. Flow %
1.74%
Top 10 Hldgs %
26.25%
Holding
735
New
61
Increased
261
Reduced
285
Closed
31

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$73.6M
2
GILD icon
Gilead Sciences
GILD
+$57M
3
MSFT icon
Microsoft
MSFT
+$44.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38.6M
5
NU icon
Nu Holdings
NU
+$38M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$112M
2
RY icon
Royal Bank of Canada
RY
+$44.3M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.1M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$38.9M
5
MRK icon
Merck
MRK
+$31.7M

Sector Composition

Rank Sector Weight
1 Technology 30.32%
2 Healthcare 28.88%
3 Consumer Discretionary 8.63%
4 Financials 8.52%
5 Industrials 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FTNT icon
326
Fortinet
FTNT
$112B
$5.09M 0.04%
86,970
-74,796
-46% -$4.13M
SDGR icon
327
Schrodinger
SDGR
$1.13B
$5.08M 0.04%
142,000
+72,000
+103% +$2.09M
BX icon
328
Blackstone
BX
$104B
$5.03M 0.03%
38,410
+174
+0.5% +$18.8K
IBN icon
329
ICICI Bank
IBN
$107B
$4.96M 0.03%
208,000
+74,000
+55% +$1.7M
CRBU icon
330
Caribou Biosciences
CRBU
$146M
$4.93M 0.03%
+860,024
New +$4.25M
SAGE
331
DELISTED
Sage Therapeutics
SAGE
$4.92M 0.03%
227,000
– –
LH icon
332
Labcorp
LH
$25.2B
$4.92M 0.03%
21,642
+2,708
+14% +$569K
ONT
333
Onterris Inc
ONT
$731M
$4.81M 0.03%
149,650
+11,875
+9% +$341K
ALV icon
334
Autoliv
ALV
$9.14B
$4.69M 0.03%
42,606
– –
BPMC
335
DELISTED
Blueprint Medicines
BPMC
$4.63M 0.03%
50,221
-85,001
-63% -$5.51M
IRON icon
336
Disc Medicine
IRON
$2.81B
$4.62M 0.03%
+80,000
New +$4.1M
KMI icon
337
Kinder Morgan
KMI
$70.9B
$4.57M 0.03%
258,917
-8,595
-3% -$146K
FDX icon
338
FedEx
FDX
$73B
$4.55M 0.03%
17,998
+513
+3% +$130K
CARR icon
339
Carrier Global
CARR
$49.8B
$4.5M 0.03%
78,368
+2,847
+4% +$151K
TMCI icon
340
Treace Medical Concepts
TMCI
$262M
$4.46M 0.03%
350,000
-77,972
-18% -$788K
RNR icon
341
RenaissanceRe
RNR
$13.8B
$4.42M 0.03%
22,557
-10,548
-32% -$2.19M
VERV
342
DELISTED
Verve Therapeutics
VERV
$4.32M 0.03%
+310,000
New +$3.84M
EOG icon
343
EOG Resources
EOG
$77.7B
$4.31M 0.03%
35,595
-106
-0.3% -$13.2K
AKRO
344
DELISTED
Akero Therapeutics
AKRO
$4.3M 0.03%
184,000
+84,000
+84% +$1.66M
TRV icon
345
Travelers Companies
TRV
$81.1B
$4.27M 0.03%
22,429
-1,022
-4% -$177K
BNTX icon
346
BioNTech
BNTX
$23.5B
$4.25M 0.03%
40,303
-20,000
-33% -$2.02M
DAWN
347
DELISTED
Day One Biopharmaceuticals
DAWN
$4.23M 0.03%
290,014
– –
ES icon
348
Eversource Energy
ES
$28.1B
$4.2M 0.03%
68,104
-31,487
-32% -$1.82M
WMB icon
349
Williams Companies
WMB
$85.8B
$4.19M 0.03%
120,355
+3,764
+3% +$132K
GWW icon
350
W.W. Grainger
GWW
$64.2B
$4.19M 0.03%
5,056
-18,751
-79% -$14.4M
12 13
14
15 16

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2023 Portfolio in Review

As of Q4 2023, Candriam SCA held 735 positions worth $14.5B, up 2.7% from $14.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Candriam SCA's Q4 2023 filing shows 61 new, 261 increased, 285 reduced and 31 closed positions. Its largest new stake was Nu Holdings: 4,696,438 shares worth $39.1M. The largest sale was Seagen Inc. Common Stock, an estimated $112M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Candriam SCA's largest Q4 2023 buy was Nu Holdings: 4,696,438 shares worth $39.1M.
  • Candriam SCA added most to Visa in Q4 2023, an estimated $73.6M increase.
  • Candriam SCA's biggest Q4 2023 reduction was Royal Bank of Canada, cutting an estimated $44.3M.
  • Candriam SCA fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $112M.
  • Candriam SCA's ten largest holdings make up 26% of its $14.5B portfolio in Q4 2023.
  • Candriam SCA opened 61 new positions and closed 31 in Q4 2023.
  • Candriam SCA's portfolio value rose 2.7% quarter-over-quarter to $14.5B.

Based on Candriam SCA's 13F filing for Q4 2023, filed 14 Feb 2024.